Neurobiology

Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Annals of the New York Academy of Sciences. 1997 Dec 29;836:158-81. Review.

Brennan PA & Raine A. Biosocial bases of antisocial behavior: Psychophysiological, neurological, and cognitive factors. Clinical Psychology Review. 1997;17(6):589-604. Review.

Cadenhead KS, Light GA, Geyer MA, et al. Neurobiological measures of schizotypal personality disorder: Defining an inhibitory endophenotype? American Journal of Psychiatry. 2002 May;159(5):869-71.

Chatterjee S, Sunitha TA, Velayudhan A, & Khanna S. An investigation into the psychobiology of social phobia: Personality domains and serotonergic function. Acta Psychiatrica Scandinavica. 1997 Jun;95(6):544-50.

Coccaro EF, Kavoussi RJ, Hauger RL, et al. Cerebrospinal fluid vasopressin levels: Correlates with aggression and serotonin function in personality-disordered subjects. Archives of General Psychiatry. 1998 Aug;55(8):708-14.

Coccaro EF, Kavoussi RJ, Sheline YI, et al. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology. 1997 Mar;16(3):211-6.

Constantino JN, Morris JA, & Murphy, DL. CSF 5-HIAA and family history of antisocial personality disorder in newborns. American Journal of Psychiatry. 1997 Dec;154(12):1771-3.

Costa L, Bauer L, Kuperman S, et al. Frontal P300 decrements, alcohol dependence, and antisocial personality disorder. Biological Psychiatry. 2000 Jun 15;47(12):1064-71.

Dickey CC, McCarley RW, Voglmaier MM, et al. Smaller left Heschl's gyrus volume in patients with schizotypal personality disorder. American Journal of Psychiatry. 2002 Sep;159(9):1521-7.

Dolan M, Anderson IM, & Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. British Journal of Psychiatry. 2001 Apr;178(4):352-9.

Gelernter J, Kranzler H, Coccaro EF, et al. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. American Journal of Psychiatry. 1998 155:1332-8.

Gurvits IG, Koenigsberg HW, & Siever LJ. Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatric Clinics of North America. 2000 Mar;23(1):27-40, vi. Review.

Kavoussi R, Armstead P, & Coccaro E. The neurobiology of impulsive aggression. Psychiatric Clinics of North America. 1997 Jun;20(2):395-403.

Kirrane RM, & Siever LJ. New perspectives on schizotypal personality disorder. Current Psychiatry Reports. 2000 Feb;2(1):62-6.

Laakso MP, Gunning-Dixon F, Vaurio O, et al. Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism. Psychiatry Research. 2002 Jun 15;114(2):95-102.

Laakso MP, Vaurio O, Koivisto E, et al. Psychopathy and the posterior hippocampus. Behavioural Brain Research. 2001 Jan 29;118(2):187-93.

Leyton M, Okazawa H, Diksic M, et al. Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. American Journal of Psychiatry. 2001 May;158(5):775-82.

Martial J, Paris J, Leyton M, et al. Neuroendocrine study of serotonin function in female borderline personality disorder patients: A pilot study. Biological Psychiatry. 1997 Oct 15;42(8):737-9.

New AS, Trestman RL, Mitropoulou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Research. 1997 Mar 3;69(l):17-26.

Oquendo MA & Mann JJ. The biology of impulsivity and suicidality. Psychiatric Clinics of North America. 2000 Mar;23(1):11-25. Review.

Rosmond R, Baghei F, Holm G, & Bjorntorp P. Relationships between personality disorders and anthropometry, hormones and metabolism in women. Journal of Endocrinological Investigation. 2001 Mar;24(3):159-65.

Sander T, Harms H, Dufeu P, et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biological Psychiatry. 1998 Jun 15;43(12):908-12.

Siever LJ. S6. Genetics and neurobiology of personality disorders. European Psychiatry. 2000 Jun;15(1):54-57.

Silk KR. Borderline personality disorder. Overview of biologic factors. Psychiatric Clinics of North America. 2000 Mar;23(1):61-75. Review.

Soderstrom H, Hultin L, Tullberg M, et al. Reduced frontotemporal perfusion in psychopathic personality. Psychiatry Research. 2002 Jun 15;114(2):81-94.

Soloff P. Special feature: Psychobiologic perspectives on treatment of personality disorders. Journal of Personality Disorders. 1997 Winter;11(4):336-44.

Steinberg BJ, Trestman R, Mitropoulou V, et al. Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology. 1997 Oct;17(4):264-73.

Svanborg P, Mattila-Evenden M, Gustavsson PJ, et al. Associations between plasma glucose and DSM-III-R cluster B personality outpatients. Neuropsychobiology. 2000 Jan;41(2):79-87.

Veit R, Flor H, Erb M, Hermann C, et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neuroscience Letters. 2002 Aug 16;328(3):233-6.

Verkes RJ, Van der Mast RC, Kerkhof AJ, et al. Platelet serotonin, MAO activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline PD. Biological Psychiatry. 1998 15;43(10):740-6.

Verkes RJ, Fekkes D, Zwinderman AH, et al. Platelet serotonin and [3H]paroxefine binding correlate with recurrence of suicidal behavior. Psychopharmacology (Berl). 1997 Jul;132(l):89-94.